Roche Canada is committed to improving the lives of Canadians impacted by rheumatological related diseases, such as rheumatoid arthritis. This commitment is evident through the support provided at both the national and provincial levels of The Arthritis Society (TAS). Roche’s support of TAS’ innovative programs and services help drive greater awareness of the disease, provide education and support to Canadians living with arthritis.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in rheumatology, oncology, virology, inflammation, metabolism and CNS. Roche Canada was founded in 1931. The company employs approximately 900 people across the country, with its pharmaceuticals head office located in Mississauga, Ontario and diagnostics division based in Laval, Quebec. Roche Canada is actively involved in local communities, investing in charitable organizations and partnering with healthcare institutions across the country.
For more information about Roche Canada visit www.rochecanada.com